Evidence map›Paper›PMID 42405545›Full record

ArticleInfection & chemotherapy2026

Antimicrobial Susceptibility of Human

Hye Gyung Bae, Jae Han Sohn, Hochan Seo, Byeonghak Kwak, Myungsook Kim, Jae-Seok Kim, Mi-Kyeong Lee, Kyungwon Lee

Abstract read
In one paragraph

Article in Infection & chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hye Gyung BaeDepartment of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea. hyegyung_bae2@scllab.co.kr.ORCID https://orcid.org/0000-0001-6399-9091
Jae Han SohnInfectious Disease Research Center, Seoul Clinical Laboratories, Yongin, Korea.ORCID https://orcid.org/0009-0006-0075-7590
Hochan SeoInfectious Disease Research Center, Seoul Clinical Laboratories, Yongin, Korea.ORCID https://orcid.org/0000-0002-2442-5084
Byeonghak KwakDepartment of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea.ORCID https://orcid.org/0009-0004-5418-1000
Myungsook KimInfectious Disease Research Center, Seoul Clinical Laboratories, Yongin, Korea.ORCID https://orcid.org/0000-0002-4933-5018
Jae-Seok KimDepartment of Laboratory Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6025-0341
Mi-Kyeong LeeDepartment of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea.ORCID https://orcid.org/0000-0002-5745-4228
Kyungwon LeeInfectious Disease Research Center, Seoul Clinical Laboratories, Yongin, Korea.ORCID https://orcid.org/0000-0003-3788-2134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMATERIALS AND

methodsA total of 70 clinical

resultsAll tested isolates were susceptible to tetracycline and TMP-SMX by disk diffusion. Susceptibility rates by disk diffusion were 97.1% for AMC, 91.4% for levofloxacin, and 85.7% for penicillin. All 10 isolates initially classified as penicillin non-susceptible by disk diffusion were confirmed to be susceptible to penicillin by MIC testing and were β-lactamase negative. The 2 isolates classified as non-susceptible to AMC by disk diffusion were also β-lactamase negative and susceptible to penicillin by MIC testing.

conclusionNo β-lactam resistance was identified among the 70 clinical

Indexed as

Antimicrobial susceptibilityBeta-lactamsDisk diffusionPasteurella multocida

Identifiers

PMID42405545
PMCPMC13338684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.